International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

PreScription: Endemics, Epidemics, and Pandemics

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s): 268

PreScription: Endemics, Epidemics, and Pandemics Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: endemic, pandemic, epidemic, COVID-19, infectious diseases

Related Categories: HISTORY, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Endemics, Epidemics, and Pandemics Allen Loyd V Jr	Jul/Aug 2021 Pg. 268
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Riepl Mike	Jan/Feb 2023 Pg. 12-21
PreScription: COVID-19 and Compounding Pharmacists Allen Loyd V Jr	Jul/Aug 2020 Pg. 268
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Riepl Mike	Mar/Apr 2023 Pg. 98-107
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment Riepl Mike, Kaiser Joe	Sep/Oct 2023 Pg. 368-380
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID Riepl Mike, Kaiser Joe	Jul/Aug 2023 Pg. 284-293
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol	Sep/Oct 2020 Pg. 358-364
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B	Mar/Apr 2021 Pg. 109-113
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Riepl Mike, Kaiser Joe	May/Jun 2023 Pg. 192-200
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L	Nov/Dec 2011 Pg. 450-457
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Brunner Scott	Jul/Aug 2021 Pg. 296-297
It's Time for a New Philosophy Brunner Scott	Sep/Oct 2021 Pg. 386-387
Calculations Stockton Shelly J	Jul/Aug 2020 Pg. 310
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
Technology Spotlight: Automated Prescription-Dispensing Systems Allen Loyd V Jr	Nov/Dec 2003 Pg. 458-459
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Harrington Amy, Williams LaVonn	Jul/Aug 2022 Pg. 293-296
Return to Top